Toll2011 Meeting, Decoding Innate Immunity

Toll2011会议，解码先天免疫

• 批准号: 8130053
• 负责人: Robert William Finberg
• 金额: $ 1.2万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-03-01 至 2012-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8130053
• 关键词: Americas; Area; Asia; Bacteria; Biological Models; Brazil; Clinical Research; Clinical Trials; Collaborations; Country; Development; Educational workshop; Environment; Europe; Evolution; Feedback; Future; Goals; Hearing; Immunology; Individual; Institution; Italy; Mind; Natural Immunity; Parasites; Participant; Physicians; Portugal; Research; Research Personnel; Science; Scientist; Series; Signal Pathway; Signal Transduction; Toll-like receptors; Virus; Virus Diseases; Work; adaptive immunity; career; fungus; innovation; lectures; meetings; microbial; novel; novel therapeutics; pathogen; peer; posters; programs; research study; symposium; therapeutic development

DESCRIPTION (provided by applicant): This application seeks support for Toll2011, the fourth in a series of meetings focused on research advances in innate immunity. The meeting is planned for May 4-7, 2011 in Riva del Garda, Italy and follows meetings in Taormina, Italy (2004), Salvador, Brazil (2006) and Cascais/Lisbon, Portugal (2008). The meeting in 2008 had over 500 participants, and the maximum amount of participants in 2011 will be close to 600. The meetings initially had a strong emphasis on recognition of microbial components (from viruses, bacteria, parasites, fungi) and signaling via Toll-like receptors, but in later years the themes have expanded to reflect a number of new signaling pathways (such as inflammasome activation) in host sensing of pathogens. Results are presented on diverse topics such as the interface between innate and adaptive immunity, model systems, evolution of innate immunity and clinical studies. Many speakers are from academic institutions in Europe, Asia, USA and other countries in the Americas, including speakers presenting on development of therapeutics related to innate immunity. The meeting intends to present cutting-edge science on many aspects related to innate immunity. PUBLIC HEALTH RELEVANCE: The study of innate immunity has been rapidly evolving and new challenges and discoveries are constantly being identified. The Toll2011 Meeting E Decoding innate immunity will bring clinicians and scientists together to exchange, discuss, and evaluate recent discoveries in the field of innate immunity and related topics. The conference will entail the following: lectures from distinguished scholars in several research aspects of innate immunity, poster sessions for young investigators to communicate their findings, and workshops where experts will debate the important topics of the day with audience participation. The goal of this meeting is to enhance understanding and disseminate available information on new developments towards understanding the underlying causes of innate immunity. The conference will also define the significant remaining scientific questions that need to be answered in order to advance future treatments for viral diseases.

描述（由申请人提供）：本申请寻求对Toll 2011的支持，Toll 2011是一系列会议中的第四次会议，重点是先天免疫的研究进展。会议计划于2011年5月4日至7日在意大利加尔达湖滨举行，并在意大利陶尔米纳（2004年）、巴西萨尔瓦多（2006年）和葡萄牙卡斯凯/里斯本（2008年）举行会议。2008年的会议有500多名与会者，2011年的与会者人数最多将接近600人。会议最初非常强调识别微生物成分（来自病毒，细菌，寄生虫，真菌）和通过Toll样受体进行信号传导，但在后来的几年中，主题已经扩展到反映宿主感知病原体的一些新的信号传导途径（如炎性小体激活）。结果呈现在不同的主题，如先天免疫和适应性免疫之间的接口，模型系统，先天免疫和临床研究的演变。许多演讲者来自欧洲、亚洲、美国和美洲其他国家的学术机构，包括介绍先天免疫相关疗法发展的演讲者。会议旨在介绍与先天免疫相关的许多方面的尖端科学。 公共卫生相关性：先天免疫的研究一直在迅速发展，新的挑战和发现不断被发现。Toll 2011会议E解码先天免疫将使临床医生和科学家聚集在一起，交流，讨论和评估先天免疫和相关主题领域的最新发现。会议将包括以下内容：杰出学者在先天免疫的几个研究方面的讲座，年轻研究人员交流他们的发现的海报会议，以及专家将与观众参与辩论当天重要主题的研讨会。本次会议的目标是加强了解和传播有关了解先天免疫根本原因的新进展的现有信息。会议还将确定需要回答的重要剩余科学问题，以推进未来的病毒性疾病治疗。